Abbott Laboratories (ABT) Debt Ratio (2016 - 2025)

Abbott Laboratories' Debt Ratio history spans 17 years, with the latest figure at 0.15 for Q3 2025.

For Q3 2025, Debt Ratio fell 23.69% year-over-year to 0.15; the TTM value through Sep 2025 reached 0.15, down 23.69%, while the annual FY2024 figure was 0.17, 13.47% down from the prior year.
Debt Ratio for Q3 2025 was 0.15 at Abbott Laboratories, down from 0.16 in the prior quarter.
Across five years, Debt Ratio topped out at 2.49 in Q4 2021 and bottomed at 0.15 in Q3 2025.
The 5-year median for Debt Ratio is 0.23 (2022), against an average of 0.44.
The largest annual shift saw Debt Ratio skyrocketed 177.97% in 2021 before it crashed 90.46% in 2023.
A 5-year view of Debt Ratio shows it stood at 2.49 in 2021, then decreased by 15.5% to 2.1 in 2022, then plummeted by 90.46% to 0.2 in 2023, then fell by 13.47% to 0.17 in 2024, then decreased by 11.39% to 0.15 in 2025.
Per Business Quant, the three most recent readings for ABT's Debt Ratio are 0.15 (Q3 2025), 0.16 (Q1 2025), and 0.17 (Q4 2024).

Peer Comparison